News - FDA Approves Abilify (Aripiprazole) for Treatment of Acute Bipolar Mania, Including Manic and Mixed Episodes

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Psychiatry Other

EXPLORE :

Most Read News

All News

All Webcasts / CME

All Cases

Congress Resource Centre

All Medical Resources

My Personal Edition

Warning | Privacy

Recent news - Psychiatry Other

	FDA Approves Valproate for Bipolar Disorder, Seizures, and Migraine Headaches - (DGNews)
	Risperidone With Standard Therapy Reduces Relapses of Bipolar Episode Regardless of Episode Type: Presented at CINP - (DGDispatch)
	Aripiprazole Safe for Schizophrenia or Bipolar 1 Disorder in Adolescents: Presented at CINP - (DGDispatch)
	New Criterion May Improve Identification of Dementia Risk in Highly Educated Older Adults - (DGNews)
	FDA Requests Boxed Warnings on Conventional Antipsychotic Drugs - (DGNews)

News archive

Recent webcasts/CME - Psychiatry Other

Advances in Alzheimer's Disease and Vascular Dementia: Benchmarks in Diagnosis and Treatment
Understanding and Differentiating Alzheimer's Disease and Vascular Dementia
Evidence-Based Guidelines for the Pharmacologic Treatment of Alzheimer's Disease and Vascular Dementia
Recent Data on Cholinesterase Inhibitors and Memantine for Alzheimer's Disease
A Comprehensive Approach to Managing Alzheimer's Disease and Vascular Dementia

Webcasts/CME archive

Recent cases - Psychiatry Other

	Factitious Lymphoedema as a Psychiatric Condition Mimicking Reflex Sympathetic Dystrophy: A Case Report
	Topiramate-Induced Psychosis in Two Members of the One Family: A Case Report
	Childhood Autism in a 13 Year Old Boy with Oculocutaneous Albinism: A Case Report
	Unexpected Depletion in Plasma Choline and Phosphatidylcholine Concentrations in a Pregnant Woman with Bipolar Affective Disorder Being Treated with Lithuim, Haloperidol and Benztropine: A Case Report
	Recognizing Thyrotoxicosis in a Patient with Bipolar Mania: A Case Report

Cases archive

my personal edition > psychiatry other > news

E-Mail this DGNews to a colleague

DGNews

FDA Approves Abilify (Aripiprazole) for Treatment of Acute Bipolar Mania, Including Manic and Mixed Episodes

NEW YORK, NY -- October 4, 2004 -- The FDA has approved Abilify® (aripiprazole), for the treatment of acute bipolar mania, including manic and mixed episodes in patients with bipolar disorder.

More than 2 million Americans suffer from bipolar I disorder, a condition that causes extreme mood changes alternating between episodes of mania (highs), when the person's mood is elated and judgment impaired, and depression (lows), when the person may feel hopeless and believe they cannot be helped.

For bipolar I disorder, medicine plays a key role in helping manage symptoms. However, taking medicine as prescribed can be difficult. Because patients vary in their response to medication, it is important to have several treatment options available to help healthcare providers find an optimal treatment plan for each patient.

SOURCE: Bristol-Myers Squibb

E-Mail this DGNews to a colleague To print, use this version